Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
City of Hope Medical Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Chest Hospital
Memorial Sloan Kettering Cancer Center
Alpha Biopharma (Jiangsu) Co., Ltd.
NYU Langone Health
Medical College of Wisconsin
Plus Therapeutics
National Cancer Institute (NCI)
Biogen
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Plus Therapeutics
Sichuan University
Northwestern University
Memorial Sloan Kettering Cancer Center
University of Virginia
Saint John's Cancer Institute
AstraZeneca
The First Hospital of Jilin University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
Mundipharma Research Limited
Duke University
Duke University
Duke University
National Cancer Institute (NCI)
Baylor College of Medicine
NYU Langone Health
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium